Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a newer version of the page. This likely reflects internal updates or fixes and does not imply changes to the displayed study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the study page.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.3 is now shown on the page. The previous revision label v3.4.2 has been removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.SummaryDifference0.4%

- Check98 days agoChange DetectedA system-wide notice about a lapse in government funding was added and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.